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OR I G I N A L R E S E A R C H
The effects of aging on sleep parameters in a
healthy, melatonin-competent mouse model
This article was published in the following Dove Press journal:
Nature and Science of Sleep
Jiffin K Paulose1
Chanung Wang1,2
Bruce F O’Hara1
Vincent M Cassone1
1Department of Biology, University of
Kentucky, Lexington, KY 40515, USA;
2Department of Neurology, Washington
University School of Medicine, St. Louis,
MO 63110, USA
Background: Sleep disturbances are common maladies associated with human age. Sleep
duration is decreased, sleep fragmentation is increased, and the timing of sleep onset and
sleep offset is earlier. These disturbances have been associated with several neurodegenera-
tive diseases. Mouse models for human sleep disturbances can be powerful due to the
accessibility to neuroscientific and genetic approaches, but these are hampered by the fact
that most mouse models employed in sleep research have spontaneous mutations in the
biosynthetic pathway(s) regulating the rhythmic production of the pineal hormone melatonin,
which has been implicated in human sleep.
Purpose and method: The present study employed a non-invasive piezoelectric measure
of sleep wake cycles in young, middle-aged and old CBA mice, a strain capable of melatonin
biosynthesis, to investigate naturally-occurring changes in sleep and circadian parameters as
the result of aging.
Results: The results indicate that young mice sleep less than do middle-aged or aged mice,
especially during the night, while the timing of activity onset and acrophase is delayed in
aged mice compared to younger mice.
Conclusion: These data point to an effect of aging on the quality and timing of sleep in
these mice but also that there are fundamental differences between control of sleep in
humans and in laboratory mice.
Keywords: sleep, circadian rhythms, aging, piezoelectric, CBA/J
Introduction
One of the most common complaints among normal, healthy aged people involves
problems with sleep.1,2 At the macro level, older people (>65 years) tend to display
longer sleep latency, decreased sleep bout length, advanced bed-time, shorter sleep
duration, and increased sleep fragmentation.3,4 There is also an increase in day-time
sleep, or naps, as humans age.5,6 These macro level changes in sleep as people age
are reflected electrophysiologically in sleep electroencephalography (EEG) in that
deeper non-rapid eye movement (nREM) slow wave sleep (SWS) EEG (stages 3
and 4) is reduced in many adults aged 75 years or older,7 while the numbers of
lighter, stage 1 and 2 nREM sleep bouts are increased.8,9 Much of the diminution in
slow wave activity (SWA) during aging occurs in the prefrontal cortex, where
decreases can be as great as 70–80% relative to younger subjects.8
These effects on sleep EEG power are believed to indicate a diminished capacity
for the “homeostatic” control of sleep,1 according to the two-process model for
sleep regulation.10,11 In this model, homeostatic sleep regulation reflects an accu-
mulation of “Process S”, resulting in the logarithmic growth of “sleep pressure” as
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we remain awake. This pressure can only be dissipated
through sleep, during which Process S declines exponen-
tially, especially with increased amplitude SWS in Stages
3 and 4 nREM sleep. During aging, it is believed that this
homeostatic sleep pressure is reduced, resulting in a
decrease in the quality of sleep.
The other process in this two process hypothesis
entails a circadian clock, “Process C”, located within
the hypothalamic suprachiasmatic nucleus (SCN), which
determines the timing of wakefulness in the human sleep:
wake cycle.12 The SCN has been demonstrated to be a
master circadian pacemaker for all mammals studied to
date. The SCN is a self-sustained circadian oscillator that
exhibits circadian rhythms in vivo and in vitro in elec-
trical, metabolic, neurosecretory and gene expression pro-
cesses. This nucleus is also necessary for circadian
rhythms, since surgical destruction of the SCN abolishes
all behavioral and physiological rhythms, including those
controlling sleep, in animal models ranging from rodents
to non-human primates. As one might expect, it would be
extremely difficult, if not impossible, to directly measure
the effects of aging on SCN function. Even so, Swaab,
Hofmann and colleagues have conducted morphometric
and immunohistochemical analyses of human SCN
obtained post-mortem.13 These authors have reported
morphometric rhythms in SCN structure and a decrease
in the numbers of neurons expressing vasoactive intest-
inal polypeptide (VIP) in aged post-mortem SCN.14
In mammals, the daily and circadian secretion of the
indoleamine hormone melatonin by the pineal gland is a
direct output of the SCN.15–17 Melatonin is secreted dur-
ing the night and reflects the length of the scotoperiod in
all mammals studied thus far, whether they are nocturnal,
diurnal or crepuscular15,17 and is known to affect sleep:
wake cycles in many species of birds and mammals.16
Afferents from the SCN are known to innervate sub-
paraventricular hypothalamic neurons, which in turn
innervate pre-ganglionic sympathetic neurons in the
intermediolateral cell column of the thoracic spinal
cord. These neurons innervate the sympathetic ganglionic
chain, including the superior cervical ganglion, which
innervates the pineal gland, where it secretes the neuro-
transmitter norepinephrine, stimulating melatonin bio-
synthesis. Destruction or blockade of any part of this
multi-synaptic pathway from the SCN to the pineal
gland abolishes melatonin biosynthesis. Thus, one way
to assess the activity of the SCN during Process C is to
measure melatonin output.
Aging in humans profoundly affects the amplitude and
phase of serum melatonin rhythms.18–21 Most studies indi-
cate that the amplitude of serum melatonin decreases dur-
ing early childhood and continues to decline to
approximately 10% of maximal levels in aged individuals
in their 70s and 80s as compared to younger subjects.18–22
In contrast, two studies describe only modest changes in
the amplitude of melatonin during aging but instead
observe changes in circadian phase, albeit in opposite
directions. Ohashi et al23 reported an advance in the mel-
atonin rhythm as subjects age, while Duffy et al24
observed a delay in the circadian phase of the melatonin
rhythm. In addition to its role as a biomarker for circadian
functions and phase, there is considerable evidence that
melatonin also contributes to the quality of sleep if admi-
nistered at the correct dosages and phases.25 These will be
discussed in the Discussion below.
The technical and ethical difficulties in studying
mechanisms of normal sleep or aging in sleep in human
subjects has led many researchers to employ animal mod-
els for sleep studies, particularly in laboratory mice. Early
EEG studies indicated a decrease in SWS and an increase
in wakefulness in healthy, aged C57BL/6J and DBA/2J
mice,26 although these authors expressed concerns that the
EEG apparatus itself was affecting the quality of sleep.27
Later studies by Welsh et al28 reported that old C57BL/6
mice exhibit increased sleep and decreased wakefulness
during the active phase of the nocturnal animals at night,
and more time awake during the resting, day-time phase.
In contrast, Wimmer et al29 did not find decreases in total
nREM sleep or increases in wakefulness in aged C57BL/6
mice. Rather, they reported aged mice do not sustain long
episodes of wakefulness or nREM sleep, but that there was
an increase in total nREM, nREM in the dark and a
decrease in overall wakefulness.
A major limitation to the study of sleep with common
laboratory strains of mouse is that the most commonly
employed strains such as inbred C57BL/6 mice are not
capable of producing melatonin due to spontaneous muta-
tions in the rate-limiting enzymes responsible for melato-
nin biosynthesis,30 whereas wild Mus musculus, CBA and
C3H mouse strains are proficient in melatonin biosynth-
esis. In the case of C57BL/6 inbred strains, a “natural
knockdown” in melatonin biosynthesis is due to a trunca-
tion in the gene encoding arylalkylamine-N-acetyltransfer-
ase (AANAT),31,32 while DBA mice exhibit a deficiency in
acetylserotonin methyl transferase (ASMT; née
hydroxyindole-O-methyl transferase; HIOMT).33 Thus,
Paulose et al Dovepress
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understanding any role for endogenous melatonin in sleep
regulation in mice is not possible in many strains of mice.
As part of a study on the effects of aging on circadian
function of the melatonin-proficient CBA mouse gastroin-
testinal system,34 we also monitored sleep wake patterns
employing a piezoelectric, non-invasive sleep monitoring
system.35,36 This system has been shown to reliably monitor
distribution of sleep, sleep quality and transitions to and
from rapid eye-movement (REM) sleep, which corresponds
favorably with EEG-determined sleep parameters.36 The
results reveal interesting insights on changes in both sleep
quality (Process S) and sleep timing (Process C) during the
aging process of melatonin proficient mice.
Methods
Animals and housing
Male CBA/J mice (National Institute of Aging, USA) at ages
4 weeks (young, n=5), 10 months (middle, n=5) and
22 months (old, n=5) were housed at the University of
Kentucky Division of Laboratory Animal Research
(UKDLAR). Before piezoelectric sleep recording, animals
were housed in 14 hrs: 10 hrs of light:dark (LD 14:10)
conditions as per UKDLAR policy. Food (Purina Mouse
chow) and water were freely available to themice throughout
the experiment. All procedures were approved by UKDLAR
and the Institutional Animal Care and Use Committee.
Animal welfare was ensured using USDA guidelines.
Piezoelectric sleep recording
Activity was recorded using a piezoelectric monitoring
system described earlier.35 The system uses piezoelectric
film to record changes in pressure, the intensity and dura-
tion of which are automatically scored by computer algo-
rithms and classified as sleep or wake. Previous use of this
system has been validated with 90% accuracy when com-
pared to EEG.36 While validation studies have not been
specifically conducted across the entire lifespan of mice or
across all mouse strains, the PiezoSleep system has been
used by over 100 investigators around the world in many
different mouse models of different ages, with no apparent
loss of accuracy in sleep-wake classification. Much of this
data is unpublished, but see additional references.37–43 The
primary concern with aged mice might be a reduction in
locomotor activity, however, locomotor activity is not a
requirement for accurate sleep vs wake determination
using the PiezoSleep system, which relies more on breath-
ing regularity during sleep, which is disrupted during even
quiet wake by subtle postural adjustments, olfactory sam-
pling (moving the nose), and other small movements that
disrupt the regular sleep signature.35,36,42,43 Mice were
housed individually for two days prior to piezoelectric
recording in a light:dark cycle of LD 12:12 and maintained
in this photoperiod until the end of recording.
Data collected from the piezoelectric system were
binned over 5 mins using a rolling average of the percent
sleep, and by individual sleep bout length from which mean
bout lengths were calculated. Sleep bouts were defined by
any contiguous sleep pattern that remained uninterrupted by
arousal periods of more than 30 seconds. In addition, bout
length counts were initiated only when a 30-second interval
contained greater than 50% sleep and were terminated when
a 30-second interval contained less than 50% sleep. Breath
rates were averaged for each individual mouse directly from
piezoelectric recordings (Figure 1). Mice were returned to
normal housing after recording for use in another study.34
Statistical analysis
Measures of sleep parameters included percent Total Sleep
over 24 hrs., percent sleep during the day-time hrs., percent
sleep in the night-time hrs., time in seconds of the average
sleep bout lengths, time in seconds of the average sleep bout
length during the day, and time in seconds of the average
sleep bout length during the night. Measures of circadian
(Process C) sleep regulation were registered in Zeitgeber
Time (ZT), where ZT0 corresponds to the time of lights on
in an LD 12:12 cycle, and ZT12 corresponds to the time of
lights off. These measures included the ZT of activity onset,
the ZTof activity offset, and the ZTof peakwake time, which
Figure 1 Breath rate as an indicator of sleep during piezoelectric recording. The
piezoelectric recording system uses breath rate to determine active vs sleep states.
Here, breath rates during sleep in young mice were significantly different than
middle-aged and old mice. Asterisk indicates p<0.05.
Dovepress Paulose et al
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were calculated using SleepStats Software (Signal Solutions,
LLC) and verified by ActogramJ.44
All graphs and statistical tests were performed in
Sigmaplot Software (Systat Software, Inc). Percent sleep and
sleep parameters were calculated for each individual mouse
and then averaged. Comparisons among young, middle-aged,
and old mice were tested using Kruskal-Wallis one-way
ANOVA on ranks with several non-parametric post-hoc tests.
For sleep measures that did not pass Kruskal-Wallis (for total
sleep over the course of the day), we applied a Dunn’s test,
while a Tukey’s HSD test was applied to those measures that
passed Kruskal-Wallis ANOVA. For circadian parameters, we
applied a Holm-Sidak method for multiple comparisons.
Results
Sleep parameters
Piezoelectric monitoring of sleep-wake cycles predicta-
bly indicated that mice were active predominantly dur-
ing the dark phase in young, middle-aged and old mice
(Figures 2A and 3). Conversely, piezoelectric measures
of sleep predominated during the light phase in all three
age groups (Figures 2B and 3). In all cases, smaller but
significant amounts of activity were detected in all age
groups during the light, while smaller but significant
sleep activity was observed during the dark.
Measures of sleep from piezoelectric analyses reveal
significant age-related changes (Figure 4). Percentage in
total sleep/24 hrs. was significantly lower in young vs both
old and middle mice (Figure 4A, p<0.05 via Dunn’s
method). Old mice exhibited more time asleep during the
day than did young and middle-aged mice (Figure 4B,
p<0.05 via Tukey’s HSD). Young mice also spent less
time asleep during the night than did middle-aged mice
(p<0.05 via Tukey’s HSD) (Figure 4C) but did not differ
from old mice.
Total sleep bout lengths were lower in middle-aged mice
than in old mice (p<0.05, Tukey’s HSD) but not different
from bout length in young mice (Figure 4D). Daytime bout
lengths in middle-aged were also lower than bout lengths in
old mice (p<0.05, Tukey’s HSD), but not different from
bout length in young mice (Figure 4E). Nighttime bout
length was significantly different between young and old
mice (P<0.05, Tukey’s HSD) (Figure 4F).
100
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Figure 2 Representative piezoelectric recordings of wake and sleep in young (green lines), middle-aged (blue lines), and old (red lines) mice. Overlaying each trace shows
greater differences in wake activity (A) vs sleep (B).
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Circadian parameters
Activity onset differed significantly between young and old
mice (Figure 5A, p<0.05, Holm-Sidak Method). Activity
offsets in both young and old mice showed greater variability
than middle-aged mice but showed no significant difference
between any age group (Figure 5B). Peak phase of activity
was significantly delayed in old mice compared to both
young and middle-aged mice (Figure 5C, p<0.05, Holm-
Sidak Method). Wakefulness in the first three hours after
dark onset, which may be interpreted as an indicator of
entrainment to the light: dark cycle, was significantly higher
in young mice compared to middle-aged and old mice
(Figure 5D, p<0.05 Tukey’s HSD).
Discussion
The present results are consistent with other studies of healthy
mouse models in that both this and previous studies26–28
indicated increases in day-time sleep, decreasing night-time
wakefulness, and increases in total amounts of sleep as mice
age. These data are also similar to at least one aspect of aging
human sleep in that both humans and our mice experience
increases in sleep during the inactive phase of their sleep-wake
cycle; for diurnal humans, there is an increase in day-time
sleep,5,6 while in mice there is an increase in night-time sleep
(Figures 2 and 4). However, they differ from studies of healthy
humans in that humans experience decreased sleep bout length
and shorter sleep durations,3,4 while mice exhibit increased
sleep bout length and increased sleep durations (Figure 4).
Similarly, circadian parameters differ during aging in humans
and mice, since humans experience earlier bed-times,1–4 while
mice exhibit a phase delay in sleep as they age (Figure 5).
Many studies have identified sleep deficits as contributing
factors in degenerative diseases such as Alzheimer’s disease
(AD), sundown syndrome and other forms of dementia,45–47
andmany of those factors have been verified through the use of
piezoelectric recording.38 Sleep disturbances are prevalent and
a highly disruptive behavioral symptom in patients with
AD.48,49 AD patients experience exacerbated disruptions in
the sleep/wake cycle such that they experience increases in
sleepiness as the disease progresses and an inability to sleep
through the night, so much so that there may be a day/night
reversal in sleep phase in the late stages of the disease.47
Additionally, a study has reported that sleep disturbances nega-
tively affect cognitive function and functional impairment in
AD patients.50 In addition, AD has been associated with dis-
ruption of circadian rhythmicity, such as increased nocturnal
activity, decreased diurnal activity, and core body temperature
phase delay and amplitude decrease, which have traditionally
been assumed to be downstream of the disease.47,51 Although
neuronal and synaptic damage byADpathology progression in
theSCN increase the dysfunction of cellular circadian rhythms,
which affects sleep disturbance in AD,52 it is not clear whether
age-related circadian disruption predisposes individuals to the
disease, or the disease induces the circadian dysfunction.47
Congruently, there is an association of melatonin bio-
synthesis and secretion with Alzheimer’s dementia.47
Levels of melatonin in blood and cerebrospinal fluid in
Alzheimer’s patients are lower than in age-matched
healthy subjects.53,54 and there is evidence that adminis-
tration of exogenous melatonin to Alzheimer’s patients
ameliorates cognitive deficits associated with the disease
in living patients as well as decreasing tau deposits in post-
Figure 3 Representative activity (left panels) and sleep (right panels) profiles of
young (top pair), middle-aged (middle pair), and old-aged (bottom pair) mice.
Within each panel, onset (green lines), peak (blue lines), and offset (red lines) as
calculated by ActogramJ are indicated.
Dovepress Paulose et al
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mortem Alzheimer’s brain tissue.55,56 It is not clear if the
progression of Alzheimer’s symptoms affects the circadian
secretion of melatonin or whether greater decreases in
melatonin levels in aged patients contributes to the pro-
gression of the disease.47 Properly timed administration of
low dosages of melatonin decreases sleep latency and
decreases sleep fragmentation in both young adult57 and
aged58 patients. Furthermore, since quality of sleep con-
tributes to the etiology of AD,41 it is likely that proper
secretion of melatonin is an important factor for the pro-
gression of normal aging as well as the diseased state.
Thus, understanding the effects of age on the sleep
patterns and other biological processes34 in a mouse strain
that is capable of synthesizing melatonin may provide a
more accurate window into the aging process. Clearly, the
fact that we see consistent changes in both sleep and
circadian parameters of sleep in our aging mice is an
encouraging sign that this may be so. However, we
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Figure 4 Effects of age on measures of sleep. (A) The percentage of time asleep is lower in young mice than in either middle-aged or old mice. (B) The percentage of time
asleep during the day is greater in old mice than in either young or middle-aged mice. (C) The percentage of time asleep during the night is lower in young mice than in either
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vs young, (b) indicates significance vs middle-aged, and (c) indicates significance vs old mice.
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recognize that there are fundamental differences between
mice and humans in sleep regulation and the effects of age
on sleep regulation that raise questions concerning the
limitations of mouse models for human health and disease.
These may derive from the simple fact that mice are
nocturnal, while humans are diurnal, and the fact that
melatonin induces sleep in humans25 and other diurnal
species, while it activates nocturnal rodent locomotor
behavior.16
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